Live better. Feel better. Look better.
The Association of the British Pharmaceutical Industry (ABPI) Code of Practice requires all companies to document and publicly disclose certain transfers of value (ToVs) made directly or indirectly to healthcare professionals (HCPs), other relevant decision makers (ORDMs) and healthcare organisations (HCOs) located in Europe, as well as to research & development (R&D) projects and patient organisations.
The Association of the British Pharmaceutical Industry (ABPI) Code of Practice requires all companies to document and publicly disclose certain transfers of value (ToVs) made directly or indirectly to healthcare professionals (HCPs), other relevant decision makers (ORDMs) and healthcare organisations (HCOs) located in Europe, as well as to research & development (R&D) projects and patient organisations.
Merz Therapeutics is committed to compliance and working within the ABPI Code of Practice and applicable laws. For payments made to HCPs/ORDMs and HCOs, including R&D projects in the last 3 years, please refer to the ABPI Disclosure Database:
Disclosure Database >Merz Therapeutics have also made the following contributions to working with patient groups:
Contributions to Patient Organisations in 2017
| Organisation | Amount | Description |
|---|---|---|
|
The Stroke Association |
£4000.00 |
Contribution towards the cost of producing stroke guides for patients |
|
Action for Dystonia, Diagnosis, Education and Research (ADDER) |
£760.00 |
Funding support for patient leaflets |
|
Chest Heart & Stroke Scotland |
£500.00 |
Contribution towards the cost of a meeting |
|
UK National Intrathecal Baclofen Trust |
£500.00 |
Contribution towards the cost of a meeting |
Contributions to Patient Organisations in 2018
| Organisation | Amount | Description |
|---|---|---|
|
The Dystonia Society |
£500.00 |
Contribution towards the cost of a meeting |
|
The Stroke Association |
£4180.00 |
Contribution towards the cost of the UK Stroke Forum Conference 2018. In return Merz UK received stand space at the event |
|
The Stroke Association |
£1250.00 |
Contribution towards the cost of the Northern Ireland Stroke Conference 2018. In return Merz UK received stand space at the event |
Contributions to Patient Organisations in 2019
| Organisation | Amount | Description |
|---|---|---|
|
Motor Neurone Disease Association |
£200.00 |
Thetford study day |
|
UK Ntl Intrathecal Baclofen Trust |
£500.00 |
Sponsorship of NIB Meeting 14.6.19 |
|
The British Voice Association |
£500.00 |
Exhibiting at the BVA event 7.7.19 |
|
The Dystonia Society |
£418.00 |
— |
Contributions to Patient Organisations in 2020
| Organisation | Amount | Description |
|---|---|---|
|
European Parkinson's Disease Association (through Merz Pharma GmbH & Co KGaA |
£30,314.00 |
EPDA's 2020 Gold Partnership tier |
|
The Dystonia Society |
£800.00 |
Dystonia UK webinar grant |
